发明授权
- 专利标题： Use of peptidic vasopressin receptor agonists
- 专利标题（中）： 使用肽加压素受体激动剂
-
申请号： US12223673申请日： 2007-02-12
-
公开(公告)号： US08222202B2公开(公告)日： 2012-07-17
- 发明人: Regent Laporte , Pierre J. M. Riviere
- 申请人： Regent Laporte , Pierre J. M. Riviere
- 申请人地址： NL
- 专利权人： Ferring B.V.
- 当前专利权人： Ferring B.V.
- 当前专利权人地址： NL
- 代理机构： Fish & Richardson P.C.
- 国际申请： PCT/IB2007/002248 WO 20070212
- 国际公布： WO2007/144768 WO 20071221
- 主分类号： A61K38/11
- IPC分类号： A61K38/11 ; C07K7/16
摘要：
The present invention relates to the use of novel compounds for the manufacture of a medicament for treatment of, inter alia, conditions associated with critical care sepsis, septic shock, hepatorenal syndrome type I, hypertension induced by endstage venal disease, severe burns, thermal injury as well as to a method for treatment of the conditions by administering the compounds. The compounds used are represented by the general formula (1), as further defined in the specification.
公开/授权文献
- US20090305959A1 Use of Peptidic Vasopressin Receptor Agonists 公开/授权日：2009-12-10
信息查询
